Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Occult hemoglobin in human stool" refers to the detection of small amounts of hemoglobin—the oxygen-carrying protein found in red blood cells—in fecal samples. This is not itself a molecular target like an enzyme or receptor but rather an analyte measured by laboratory tests such as the fecal occult blood test (FOBT). The presence of occult hemoglobin indicates hidden gastrointestinal tract bleeding that may result from various causes including polyps, colorectal cancer, ulcers, inflammatory bowel disease, hemorrhoids, and other lesions. Detection methods include chemical-based guaiac tests and immunoassays that specifically bind to human hemoglobin. The main clinical use is as a noninvasive screening tool for early detection of colorectal cancer and other sources of GI tract bleeding. A positive test result warrants further diagnostic procedures but does not specify the underlying cause or location[1][2][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hemoglobin (as detected in human stool).